✦ New CED Clinical Relevance #95 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. PolicyResearchIndustry Clinical Perspective 🏥 The legal status of cannabis remains highly fragmented across...
As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely
✦ New CED Clinical Relevance #95 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. PolicyResearchSafety Why This Matters I don't see a summary provided in your request....
In the Mix: 5 More Articles — March 15, 2026
In the Mix — Last 24 HoursMarch 15, 2026. 5 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Budget Battle, Clyburn to Run Again,...
New Top Cannabis Regulator Sets Priorities In First Board Meeting
✦ New CED Clinical Relevance #96 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. PolicyIndustrySafety Why This Matters I don't see a summary provided in your message....
Quasi-randomization to Cannabinoid Condition in Studies of US Legal Market Cannabis
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicySafety Why This Matters Clinicians need to understand that most cannabis efficacy data comes from...
This Week in Cannabis: March 13, 2026
Weekly RoundupThis week, cannabis coverage focused on federal reclassification impacts, clinical research into CBD and cannabinoids for health conditions, and regulatory policy updates.Friday, March 13, 2026 — top 5 across News, Studies,...
Marijuana Rescheduling Is A ‘Transitional’ Step That Must Be Followed By Banking …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary Federal rescheduling of marijuana from Schedule I to Schedule III would represent...
In the Mix: 5 More Articles — March 13, 2026
In the Mix — Last 24 HoursMarch 13, 2026. 5 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 Marijuana reclassification may impact drug...
IRS Files First Response to Common Industry 280E Arguments | Harris Beach Murtha – JDSupra
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters The IRS’s response to Section 280E tax deduction arguments directly impacts...
In the Mix: 7 More Articles — March 12, 2026
In the Mix — Last 24 HoursMarch 12, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 IRS Files First Response to...